Disclosed herein are compounds for activating the Reelin signaling system for the treatment of neurological disorders. Further provided are compounds and methods for activating a lipoprotein receptor, such as ApoER2 or VLDLR. Neuroscience, Medical
Neurosciences Neurochemistry Neurology Neuropharmacology
11629127
11306059
11,306,059